A phase 1 study of venetoclax (ABT-199 / GDC-0199) monotherapy in patients with relapsed/refractory non-Hodgkin lymphoma Meeting Abstract


Authors: Gerecitano, J. F.; Roberts, A. W.; Seymour, J. F.; Wierda, W. G.; Kahl, B. S.; Pagel, J. M.; Puvvada, S.; Kipps, T. J.; Anderson, M. A.; Dunbar, M.; Zhu, M.; Gressick, L.; Wagner, L.; Kim, S. Y.; Enschende, S. H.; Humerickhouse, R. A.; Davids, M. S.
Abstract Title: A phase 1 study of venetoclax (ABT-199 / GDC-0199) monotherapy in patients with relapsed/refractory non-Hodgkin lymphoma
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368019001006
PROVIDER: wos
DOI: 10.1182/blood.V126.23.254.254
Notes: Meeting Abstract: 254 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors